Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer

Oncogene

Volumn 33, Issue 50, 2014, Pages 5729-5739

  Haricharan, S ^a   Hein, S M ^a   Dong, J ^a   Toneff, M J ^a   Aina, O H ^b   Rao, P H ^a   Cardiff, R D ^b   Li, Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alveolar cells; breast cancer; PABC; pregnancy

Indexed keywords

ANIMAL; CANCER GRADING; CANCER STEM CELL; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; HUMAN; MOUSE; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; TRANSGENIC MOUSE; UDDER; VIRUS CELL TRANSFORMATION;

ANIMALS; CELL TRANSFORMATION, VIRAL; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM GRADING; NEOPLASTIC STEM CELLS; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 84889010615     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.521     Document Type: Article

References (42)

1. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006; 6: 281-291.
2. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003; 98: 1055-1060.
3. Mathelin C, Annane K, Treisser A, Chenard MP, Tomasetto C, Bellocq JP et al. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 2008; 28: 2447-2452.
4. Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R. Pregnancyassociated breast cancers: do they differ from other breast cancers in young women? Breast 2012; 21: 550-555.
5. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009; 14: 87-98.
6. Fornetti J, Martinson H, Borges V, Schedin P. Emerging targets for the prevention of pregnancy-associated breast cancer. Cell Cycle 2012; 11: 639-640.
7. Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011; 17: 1109-1115.
8. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L et al. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2010; 176: 1241-1255.
9. Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J et al. Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol 2012; 19: 1167-1173.
10. Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27: 45-51.
11. O'Brien J, Hansen K, Barkan D, Green J, Schedin P. Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular matrix of the postpartum mammary gland. Int J Dev Biol 2011; 55: 745-755.
12. Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 2008; 135: 995-1003.
13. Robinson GW, McKnight RA, Smith GH, Hennighausen L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 1995; 121: 2079-2090.
14. Yamaji D, Na R, Feuermann Y, Pechhold S, Chen W, Robinson GW et al. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 2009; 23: 2382-2387.
15. Khaled WT, Read EK, Nicholson SE, Baxter FO, Brennan AJ, Came PJ et al. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development 2007; 134: 2739-2750.
16. Smith GH, Boulanger CA. Mammary epithelial stem cells: transplantation and self-renewal analysis. Cell Prolif 2003; 36(Suppl 1): 3-15.
17. Bu W, Chen J, Morrison GD, Huang S, Creighton CJ, Huang J et al. Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene 2011; 30: 4399-4409.
18. Ince TA, Richardson AL, Bell GW, Saitoh M, Godar S, Karnoub AE et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 2007; 12: 160-170.
19. Proia TA, Keller PJ, Gupta PB, Klebba I, Jones AD, Sedic M et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 2011; 8: 149-163.
20. Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S et al. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA 2012; 109: 2772-2777.
21. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010; 7: 403-417.
22. Bu W, Zhang X, Dai H, huang S, Li Y. Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis. PLoS One 2013; 8: e78720.
23. Du Z, Podsypanina K, Huang S, McGrath A, Toneff MJ, Bogoslovskaia E et al. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc Natl Acad Sci USA 2006; 103: 17396-17401.
24. Reddy JP, Li Y. The RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo. J Mammary Gland Biol Neoplasia 2009; 14: 405-409.
25. Toneff MJ, Du Z, Dong J, Huang J, Sinai P, Forman J et al. Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis. Neoplasia 2010/09; 12: 718-726.
26. Cruz GI, Martinez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M et al. Hypothesized role of pregnancy hormones on HER2+ breast tumor development. Breast Cancer Res Treat 2013; 137: 237-246.
27. Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 2009; 9: 463-475.
28. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008; 8: 387-398.
29. Brisken C. Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia 2002; 7: 39-48.
30. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 1997; 11: 179-186.
31. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML et al. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439: 84-88.
32. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011; 479: 189-193.
33. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B et al. Age at first birth and breast cancer risk. Bull World Health Organ 1970; 43: 209-221.
34. Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res 2004; 10(1 Pt 2): 380S-384SS.
35. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987; 56: 814-819.
36. Welch HG, Black WC. Using autopsy series to estimate the disease 'reservoir' for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 1997; 127: 1023-1028.
37. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987; 60: 2751-2760.
38. Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P et al. Estrogen receptor status in BRCA1-and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 2004; 10: 2029-2034.
39. Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N et al. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer 2012; 118: 3254-3259.
40. Campbell SM, Rosen JM, Hennighausen LG, Strech-Jurk U, Sippel AE. Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res 1984; 12: 8685-8697.
41. Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci USA 1998; 95: 1218-1223.
42. Bu W, Xin L, Toneff M, Li L, Li Y. Lentivirus vectors for stably introducing genes into mammary epithelial cells in vivo. J Mammary Gland Biol Neoplasia 2009; 14: 401-404.